Previous studies either focused on how to use aripiprazole to deal with antipsychotic-induced hyperprolactinemia [3–7], or whether aripiprazole might worsen psychosis in the long run [8, 9], with none evaluating the dynamic relationship between aripiprazole-induced abnormally low PRL and a rebound in psychotic symptoms. Here, PRL is linked to psychotic disorder.